Evonik Evonik

X

Find Erythromyclamine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Erythromyclamine
Also known as: Erythromycylamine, 26116-56-3, 9(s)-erythromycylamine, 9-epierythromycylamine, (9s)-erythromycyclamine, Brn 4241492
Molecular Formula
C37H70N2O12
Molecular Weight
735.0  g/mol
InChI Key
XCLJRCAJSCMIND-JCTYMORFSA-N
FDA UNII
YX9KV1OMA4

1 2D Structure

Erythromyclamine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3R,4S,5S,6R,7R,9R,10S,11S,12R,13S,14R)-10-amino-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
2.1.2 InChI
InChI=1S/C37H70N2O12/c1-14-25-37(10,45)30(41)20(4)27(38)18(2)16-35(8,44)32(51-34-28(40)24(39(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-32,34,40-42,44-45H,14-17,38H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,27+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1
2.1.3 InChI Key
XCLJRCAJSCMIND-JCTYMORFSA-N
2.1.4 Canonical SMILES
CCC1C(C(C(C(C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)N)C)O)(C)O
2.1.5 Isomeric SMILES
CC[C@@H]1[C@@]([C@@H]([C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)N)C)O)(C)O
2.2 Other Identifiers
2.2.1 UNII
YX9KV1OMA4
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 9(s)-erythromycylamine

2. Erythromyclamine

3. Erythromyclamine, (9r)-isomer

4. Erythromyclamine, (9s)-isomer

2.3.2 Depositor-Supplied Synonyms

1. Erythromycylamine

2. 26116-56-3

3. 9(s)-erythromycylamine

4. 9-epierythromycylamine

5. (9s)-erythromycyclamine

6. Brn 4241492

7. (9s)-erythromycylamine A

8. Erythromycin, 9-amino-9-deoxo-, (9s)-

9. Yx9kv1oma4

10. 9-amino-9-deoxoerythromycin

11. Chembl290242

12. Chebi:73708

13. Ly-24410

14. Epierythromycyl-a-amine

15. (3r,4s,5s,6r,7r,9r,10s,11s,12r,13s,14r)-10-amino-6-(((2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one

16. (9s)-9-amino-9-deoxyerythromycin

17. 9-amino-9-deoxo-erythromycin, Stereoisomer

18. (3r,4s,5s,6r,7r,9r,10s,11s,12r,13s,14r)-10-amino-6-{[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one

19. (9s)-9-deoxy-9-aminoerythromycin A

20. Unii-yx9kv1oma4

21. Erythromycin, 9-amino-9-deoxo-, Stereoisomer

22. Ec 406-790-7

23. Erythromycin, 9-amino-9-deoxo-, (9s)- (9ci)

24. Schembl13681694

25. Brl-42852er

26. Dtxsid00180750

27. Ex-a5468

28. Bdbm50417963

29. Mfcd00872156

30. Zinc94303289

31. Akos037651084

32. (3r,4s,5s,6r,7r,9r,10s,11s,12r,13s,14r)-10-amino-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one

33. Ac-28327

34. Cs-15835

35. Ly-024410

36. Cs-0047729

37. D95598

38. J-016261

39. Q27144058

40. (3r,4s,5s,6r,7r,9r,10s,11s,12r,13s,14r)-10-amino-6-{[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2h-py

41. (3r,4s,5s,6r,7r,9r,10s,11s,12r,13s,14r)-10-amino-6-{[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one (non-preferred Name)

42. Ern

43. Ran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl]oxy

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 735.0 g/mol
Molecular Formula C37H70N2O12
XLogP33.5
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count14
Rotatable Bond Count7
Exact Mass734.49287567 g/mol
Monoisotopic Mass734.49287567 g/mol
Topological Polar Surface Area203 Ų
Heavy Atom Count51
Formal Charge0
Complexity1140
Isotope Atom Count0
Defined Atom Stereocenter Count19
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY